A nitric oxide-boosting molecular agent to enhance mild-temperature photothermal therapy
Chemical Communications · 2025 · 61 (21) · 4212-4215
DOI: 10.1039/d5cc00219b ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2025. Verfasst von Xinhao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative I…. Hauptthemen laut MEDLINE: Nitric Oxide, Photothermal Therapy, Temperature, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
A molecular agent was developed for enhanced mild-temperature photothermal therapy through producing NO, inhibiting heat shock proteins, and reversing tumor thermoresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Univ…
- Laoshan Laboratory, Qingdao, 266237, P. R. China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhang, X., Pan, W., Kuang, J., Wang, K., Li, N., & Tang, B. (2025). A nitric oxide-boosting molecular agent to enhance mild-temperature photothermal therapy. Chemical Communications, 61(21), 4212-4215. https://doi.org/10.1039/d5cc00219b
Vancouver
Zhang X, Pan W, Kuang J, Wang K, Li N, Tang B. A nitric oxide-boosting molecular agent to enhance mild-temperature photothermal therapy. Chemical Communications. 2025;61(21):4212-4215. doi:10.1039/d5cc00219b
BibTeX
@article{Zhang2025,
author = {Zhang, Xinhao and Pan, Wei and Kuang, Jialin and Wang, Kaiye and Li, Na and Tang, Bo},
title = {A nitric oxide-boosting molecular agent to enhance mild-temperature photothermal therapy},
journal = {Chemical Communications},
year = {2025},
volume = {61},
number = {21},
pages = {4212--4215},
doi = {10.1039/d5cc00219b}
}
EUVIMED